Common Contracts
2 similar License Agreement contracts by Bioventus Inc.
AMENDED AND RESTATED LICENSE AGREEMENT – US BETWEEN BIOVENTUS LLC AND Q-MED AB AND NESTLÉ SKIN HEALTH S.A. December 9, 2016License Agreement • January 20th, 2021 • Bioventus Inc. • Surgical & medical instruments & apparatus • New York
This Amended and Restated License Agreement – US (together with all schedules and exhibits attached hereto, the “Agreement”), is made and entered into this December 9, 2016 (the “Amendment Effective Date”), by and among Q-Med AB, a limited liability company organized under the laws of the Kingdom of Sweden with corporate registration number 556258-6882 (“Q-Med”), Nestlé Skin Health S.A., a corporation organized under the laws of Switzerland (“NSH”), and Bioventus LLC, a limited liability company organized under the laws of Delaware (“Bioventus”). Each of (i) Q-Med and NSH, on the one hand, and (ii) Bioventus, on the other hand, shall be referred to herein as a “Party” and collectively as the “Parties.” This Agreement shall amend, supersede and replace the Current US License Agreement (as defined below).
AMENDED AND RESTATED LICENSE AGREEMENT – US BETWEEN BIOVENTUS LLC AND Q-MED AB AND NESTLÉ SKIN HEALTH S.A. December 9, 2016License Agreement • November 10th, 2020 • Bioventus Inc. • Surgical & medical instruments & apparatus • New York
This Amended and Restated License Agreement – US (together with all schedules and exhibits attached hereto, the “Agreement”), is made and entered into this December 9, 2016 (the “Amendment Effective Date”), by and among Q-Med AB, a limited liability company organized under the laws of the Kingdom of Sweden with corporate registration number 556258-6882 (“Q-Med”), Nestlé Skin Health S.A., a corporation organized under the laws of Switzerland (“NSH”), and Bioventus LLC, a limited liability company organized under the laws of Delaware (“Bioventus”). Each of (i) Q-Med and NSH, on the one hand, and (ii) Bioventus, on the other hand, shall be referred to herein as a “Party” and collectively as the “Parties.” This Agreement shall amend, supersede and replace the Current US License Agreement (as defined below).
